MEDS

Healthcare Medical Distribution

DataMEDS AI, Inc.

$3.07

-0.19 -5.83% today

Price History

Not enough data

Key Stats

Market Cap

8.70M

Avg Volume

5.72M

EPS

-$46.68

52W High

$73.00

52W Low

$0.82

Div. Yield

0.0%

Valuation

P/B Ratio

-0.45

P/S Ratio

1.08

EV/EBITDA

-0.73

EV/Revenue

5.04

Margins

Gross Margin (90.6%)

Operating Margin (412.7%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(77.2%)

Return on Assets

(82.9%)

Liquidity & Leverage

Current Ratio

0.14

Quick Ratio

0.09

Total Cash

2.46M

Total Debt

32.62M

About

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services. DataMEDS AI, Inc., through its subsidiary develops and delivers a portfolio of products to guide physicians and patients with difficult clinical decisions throughout the cancer care continuum. In addition, the company develops and provides functional precision medicine oncology platform. The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.

datamedsai.com